Summary
Updated Aug 31, 2026
Julia P. Gregory is Director of Nurix Therapeutics, Inc. (NRIX). 5 SEC Form 4 filings on record going back to 2025, most recently on 15 May 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Julia P. Gregory has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Julia P. Gregory files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John W. Childs - $25.86M of BHVN open-market activity in the last 12 months
- Vlad Coric - $5.00M of BHVN open-market activity in the last 12 months
- Christine Ring - $3.05M of NRIX open-market activity in the last 12 months
- Gregory Bailey - $3.00M of BHVN open-market activity in the last 12 months
- Houte Hans van - $635K of NRIX open-market activity in the last 12 months
- Gwenn Hansen - $485K of NRIX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Julia P. Gregory?
Julia P. Gregory is a corporate insider, tracked as Director of Nurix Therapeutics, Inc. (NRIX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Julia P. Gregory last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 5 filings going back to 2025.
Where can I see all of Julia P. Gregory's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Julia P. Gregory and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
